Companies Dominating the Digital Biomarker Landscape
- IMVARIA Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- nQ Medical
- ALTOIDA
- ActiGraph, LLC.
- VivoSense
- EVOCAL Health GmbH
- Koneksa Health
- Cosinuss GmbH
- Biofourmis
- Lunit Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Digital Biomarkers Market in 2025 is assessed at USD 4.77 billion.
The global market size surpassed USD 3.79 billion in 2024 and is projected to witness a CAGR of over 32.2%, crossing USD 142.77 billion revenue by 2037.
North America is estimated to accumulate USD 64.25 billion by 2037, driven by a sharp rise in Alzheimer’s cases.
The major players in the market include IMVARIA Inc., nQ Medical, ALTOIDA, ActiGraph, LLC., VivoSense, EVOCAL Health GmbH, Koneksa Health, Cosinuss GmbH, Biofourmis, Lunit Inc.
